Division of Reproductive Medicine, West China Second University Hospital of Sichuan University, Chengdu, China.
Key Laboratory of Birth Defects and Related Diseases of Women and Children of Ministry of Education, Chengdu, China.
Int J Gynaecol Obstet. 2024 Sep;166(3):1345-1350. doi: 10.1002/ijgo.15522. Epub 2024 Apr 5.
Despite its widespread use, in vitro fertilization (IVF) outcomes are challenged by implantation failure, largely due to factors such as embryo quality and endometrial receptivity. In this study, we investigated the clinical effect of office hysteroscopy (OH) on the subsequent frozen-thawed embryo transfer (FET) in infertile women who experienced a failed IVF-embryo transfer (IVF-ET) cycle.
We included 577 infertile women who underwent OH because of a history of failed ET between October 2019 and September 2021. During OH, visible endometrial polyps (EPs) were diagnosed and removed by curette or biopsy forceps; chronic endometritis (CE) was diagnosed by histopathology and immunohistochemistry and treated with oral doxycycline (0.2 g/d) for 14 days. According to the hysteroscopic findings and endometrial pathology with immunohistochemistry, patients were divided into three groups: group A (n = 161) had CE with or without EPs, group B (n = 156) had EPs only, and group C (n = 260) had no CE or EPs.
In the following FET cycle, the implantation rates were 47%, 51%, and 45% (P = 0.411); the clinical pregnancy rates were 56%, 62%, and 55% (P = 0.436); the live birth rates were 45%, 51%, and 42% (P = 0.205); and the miscarriage rates were 18%, 16%, and 22% (P = 0.497) in groups A, B, and C, respectively. There were no significant differences among groups (P > 0.05).
OH is helpful for diagnosis and treatment of abnormal intrauterine environment in women with a failed IVF cycle and further improves their pregnancy outcome in the following FET.
尽管体外受精(IVF)被广泛应用,但胚胎着床失败仍是其面临的挑战,主要与胚胎质量和子宫内膜容受性等因素有关。本研究旨在探讨宫腔镜检查(OH)对反复体外受精-胚胎移植(IVF-ET)失败患者后续冻融胚胎移植(FET)的临床效果。
本研究纳入了 2019 年 10 月至 2021 年 9 月期间因 ET 失败而接受 OH 的 577 例不孕妇女。OH 中,通过刮宫或活检钳诊断和切除可见的子宫内膜息肉(EPs);通过组织病理学和免疫组织化学诊断慢性子宫内膜炎(CE),并给予口服多西环素(0.2g/d)治疗 14 天。根据宫腔镜检查结果和子宫内膜免疫组化病理,将患者分为三组:A 组(n=161),CE 合并或不合并 EPs;B 组(n=156),EPs 仅;C 组(n=260),无 CE 或 EPs。
在随后的 FET 周期中,A、B、C 组的着床率分别为 47%、51%和 45%(P=0.411);临床妊娠率分别为 56%、62%和 55%(P=0.436);活产率分别为 45%、51%和 42%(P=0.205);流产率分别为 18%、16%和 22%(P=0.497)。三组间差异均无统计学意义(P>0.05)。
OH 有助于诊断和治疗 IVF 失败周期中异常的宫腔内环境,进一步提高后续 FET 患者的妊娠结局。